Saturday, June 25, 2022

A company insider recently sold 6,000 shares of Dynavax Technologies Corporation [DVAX]. Should You Sale?

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Dynavax Technologies Corporation shares valued at $60,000 were sold by Burgess Justin on May 17. At $10.00 per share, Burgess Justin sold 6,000 shares. The insider’s holdings dropped to 3,854 shares worth approximately $44321.0 following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Also, Novack David F sold 41,862 shares, netting a total of over 442,481 in proceeds. Following the sale of shares at $10.57 each, the insider now holds 73,213 shares.

Before that, Spencer Ryan had sold 83,108 shares from its account. In a trade valued at $877,923, the CEO and Director traded Dynavax Technologies Corporation shares for $10.56 each. Upon closing the transaction, the insider’s holdings decreased to 83,108 shares, worth approximately $1.49 million.

As published in their initiating research note from Maxim Group on June 22, 2017, Good Times Restaurants Inc. [GTIM] has been a Buy and the price target has been revised to $6. This represents a 54.33% premium over Wednesday’s closing price. Analysts at Craig Hallum upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early September. As of May 14, 2015, Craig Hallum has decreased its “Buy” rating to a “Hold” for GTIM. Earlier on February 17, 2015, ROTH Capital resumed its rating. Their recommendation was “a Buy” for GTIM stock.

This represents a 69.74% premium over Wednesday’s closing price. Analysts at Goldman started covering the stock with ‘”a Buy”‘ outlook in a report released in early August. As of August 07, 2020, H.C. Wainwright has reiterated its “Buy” rating for DVAX. Earlier on August 03, 2020, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for DVAX stock.

Analyzing DVAX’s Price Performance

On Wednesday, Dynavax Technologies Corporation [NASDAQ: DVAX] rose 4.26% to $11.50. The stock’s lowest price that day was $10.62, but it reached a high of $11.76 in the same session. During the last five days, there has been a surge of approximately 9.84%. Over the course of the year, Dynavax Technologies Corporation shares have dropped approximately -18.27%. Shares of the company reached a 52-week high of $14.84 on 01/11/22 and a 52-week low of $7.26 on 05/12/22. A 50-day SMA is recorded $10.36, while a 200-day SMA reached $13.49. Nevertheless, trading volume fell to 1.69 million shares from 2.26 million shares the previous day.

Support And Resistance Levels for Dynavax Technologies Corporation (DVAX)

According to the 24-hour chart, there is a support level at 10.83, which, if violated, would cause prices to drop to 10.15. In the upper region, resistance lies at 11.97. The next price resistance is at 12.43. RSI (Relative Strength Index) is 54.53 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.44, which suggests the price will decrease in the coming days. Percent R is at 46.56%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Which companies own the most shares of Dynavax Technologies Corporation (DVAX)?

According to Federated Global Investment Manag filings, the company currently owns 16,537,838 shares, which is about 13.09% of the total DVAX shares outstanding. The investor’s shares have appreciated by 330,000 from its previous 13-F filing of 16207838.0 shares. With the completion of the buy, SSgA Funds Management, Inc.’s stake is now worth $100,794,962. BlackRock Fund Advisors reduced a -0.85% interest valued at $78.71 million while Chicago Capital LLC purchased a 121,678 stake. A total of -57,647 shares of Dynavax Technologies Corporation were bought by The Vanguard Group, Inc. during the quarter, and 0 were sold by PFM Health Sciences LP. In its current portfolio, Fisher Asset Management LLC holds 3,511,165 shares valued at $41.64 million.

Latest news

Related news


Please enter your comment!
Please enter your name here




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam